These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32971586)

  • 1. The effect of moderate alcohol drinking in nonalcoholic fatty liver disease.
    Choi JH; Sohn W; Cho YK
    Clin Mol Hepatol; 2020 Oct; 26(4):662-669. PubMed ID: 32971586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease.
    Mitchell T; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Ching H; Hamdorf J; Adams LA
    Am J Gastroenterol; 2018 Oct; 113(10):1484-1493. PubMed ID: 29899440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus.
    Blomdahl J; Nasr P; Ekstedt M; Kechagias S
    Metabolism; 2021 Feb; 115():154439. PubMed ID: 33246008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study.
    Chang Y; Cho YK; Kim Y; Sung E; Ahn J; Jung HS; Yun KE; Shin H; Ryu S
    Hepatology; 2019 Jan; 69(1):64-75. PubMed ID: 30019340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.
    Hagström H; Nasr P; Ekstedt M; Kechagias S; Önnerhag K; Nilsson E; Rorsman F; Sheikhi R; Marschall HU; Hultcrantz R; Stål P
    Scand J Gastroenterol; 2017 Feb; 52(2):159-165. PubMed ID: 27650916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate alcohol consumption is not associated with subclinical cardiovascular damage but with hepatic fibrosis in non-alcoholic fatty liver disease.
    Kashiwagi K; Yamaguchi A; Shiba S; Taniki N; Inoue N; Takaishi H; Iwao Y; Kanai T
    Alcohol; 2020 Dec; 89():1-7. PubMed ID: 32738385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
    Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
    Ajmera VH; Terrault NA; Harrison SA
    Hepatology; 2017 Jun; 65(6):2090-2099. PubMed ID: 28100008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease.
    Zheng T; Wang X; Kamili K; Luo C; Hu Y; Wang D; Wang B; Gao P; Tian G
    Scand J Gastroenterol; 2024 Apr; 59(4):480-488. PubMed ID: 38179969
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of alcohol consumption on nonalcoholic fatty liver disease.
    Weng G; Dunn W
    Transl Gastroenterol Hepatol; 2019; 4():70. PubMed ID: 31620652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.
    Kimura T; Tanaka N; Fujimori N; Sugiura A; Yamazaki T; Joshita S; Komatsu M; Umemura T; Matsumoto A; Tanaka E
    World J Gastroenterol; 2018 Apr; 24(13):1440-1450. PubMed ID: 29632425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis.
    Di Ciaula A; Bonfrate L; Krawczyk M; Frühbeck G; Portincasa P
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
    Younossi ZM; Stepanova M; Ong J; Yilmaz Y; Duseja A; Eguchi Y; El Kassas M; Castellanos-Fernandez M; George J; Jacobson IM; Bugianesi E; Wong VW; Arrese M; de Ledinghen V; Romero-Gomez M; Mendez-Sanchez N; Ahmed A; Wong R; Papatheodoridis G; Serfaty L; Younossi I; Nader F; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1625-1633.e1. PubMed ID: 30476585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease.
    Ferri S; Stefanini B; Mulazzani L; Alvisi M; Tovoli F; Leoni S; Muratori L; Lotti T; Granito A; Bolondi L; Piscaglia F
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the role of alcohol consumption and qualitative abdominal fat on NAFLD and MAFLD in males and females.
    Sogabe M; Okahisa T; Kurihara T; Kagawa M; Ueda H; Kawaguchi T; Fukuya A; Kagemoto K; Tanaka H; Kida Y; Tomonari T; Taniguchi T; Okamoto K; Miyamoto H; Sato Y; Nakasono M; Takayama T
    Sci Rep; 2022 Sep; 12(1):16048. PubMed ID: 36163355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD.
    Blomdahl J; Nasr P; Ekstedt M; Kechagias S
    Hepatol Commun; 2023 Jan; 7(1):e0003. PubMed ID: 36633482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease.
    Kwon I; Jun DW; Moon JH
    Gut Liver; 2019 May; 13(3):308-314. PubMed ID: 30400736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mendelian randomisation suggests no beneficial effect of moderate alcohol consumption on the severity of nonalcoholic fatty liver disease.
    Sookoian S; Flichman D; Castaño GO; Pirola CJ
    Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1224-1234. PubMed ID: 27778410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions.
    Åberg F; Färkkilä M
    Semin Liver Dis; 2020 May; 40(2):154-162. PubMed ID: 32069503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.